Health TidingsOno Pharmaceutical’s Tirabrutinib NDA Accepted by FDA for R/R PCNSL Ono Pharmaceutical’s Tirabrutinib NDA Accepted by FDA for R/R PCNSL Read Post »
Health TidingsLilly’s Retevmo Improves Event-Free Survival in Early RET+ NSCLC Lilly’s Retevmo Improves Event-Free Survival in Early RET+ NSCLC Read Post »
Health TidingsNeedle-Free neffy: Launches in Australia for Anaphylaxis Needle-Free neffy: Launches in Australia for Anaphylaxis Read Post »
Health TidingsEisai Secures Orphan Drug Designation in Japan for E2086 in Narcolepsy Eisai Secures Orphan Drug Designation in Japan for E2086 in Narcolepsy Read Post »
Health TidingsOtsuka’s REXULTI Added to Japan’s Disaster Essential Medicines List Otsuka’s REXULTI Added to Japan’s Disaster Essential Medicines List Read Post »
Health TidingsDisc Medicine Gets FDA CRL for Bitopertin, Eyes APOLLO Trial Disc Medicine Gets FDA CRL for Bitopertin, Eyes APOLLO Trial Read Post »
Health TidingsPTC Pulls Ataluren NDA for nmDMD After FDA Review Feedback PTC Pulls Ataluren NDA for nmDMD After FDA Review Feedback Read Post »
Health TidingsINmune Bio Files MHRA Pre-Submission for CORDStrom in RDEB INmune Bio Files MHRA Pre-Submission for CORDStrom in RDEB Read Post »
Health TidingsNovo Nordisk Targets Access and Flexibility with Planned Wegovy Vials Novo Nordisk Targets Access and Flexibility with Planned Wegovy Vials Read Post »
Health TidingsOutlook Therapeutics Seeks FDA Type A Meeting Following CRL for LYTENAVA™... Outlook Therapeutics Seeks FDA Type A Meeting Following CRL for LYTENAVA™... Read Post »
Health TidingsREGENXBIO Unveils 2026 Pipeline Catalysts with Strong 18-Month DMD Trial Da... REGENXBIO Unveils 2026 Pipeline Catalysts with Strong 18-Month DMD Trial Da... Read Post »
Health TidingsDewpoint MYC Condensate Modulator Hits DC Stage Dewpoint MYC Condensate Modulator Hits DC Stage Read Post »
Health TidingsAstellas Secures $210 Million in Settlements with Lupin and Zydus Over Myrb... Astellas Secures $210 Million in Settlements with Lupin and Zydus Over Myrb... Read Post »
Health Tidings Policy & AcquisitionsSanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Sanofi Closes Dynavax Deal, Expands Presence in Adult Vaccines Read Post »
Health Tidings Policy & AcquisitionsChugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Chugai Licenses Araris’ AraLinQ® Platform to Advance Next-Generation ADC... Read Post »
Health TidingsFDA Issues Refusal-to-File Letter for Moderna’s mRNA-1010 Flu Vaccine FDA Issues Refusal-to-File Letter for Moderna’s mRNA-1010 Flu Vaccine Read Post »
Food Health TidingsFDA Initiates Priority Safety Review of BHA Used in Foods FDA Initiates Priority Safety Review of BHA Used in Foods Read Post »
Health TidingsIambic, Takeda Team Up on AI-Driven Small Molecule Discovery Iambic, Takeda Team Up on AI-Driven Small Molecule Discovery Read Post »
Health TidingsAstellas Pharma Inc. Settles U.S. Patent Litigation with Lupin Limited Over... Astellas Pharma Inc. Settles U.S. Patent Litigation with Lupin Limited Over... Read Post »
Health TidingsFDA Issues CRL for REGENXBIO’s RGX-121 in MPS II FDA Issues CRL for REGENXBIO’s RGX-121 in MPS II Read Post »
Health TidingsNovo Nordisk Files Semaglutide Lawsuit Against Hims Novo Nordisk Files Semaglutide Lawsuit Against Hims Read Post »
Health TidingsEisai and Biogen Secure Priority Review in China for Subcutaneous LEQEMBI Eisai and Biogen Secure Priority Review in China for Subcutaneous LEQEMBI Read Post »
Health TidingsSanofi’s Rilzabrutinib Gains FDA Breakthrough Therapy Designation, Ja... Sanofi’s Rilzabrutinib Gains FDA Breakthrough Therapy Designation, Ja... Read Post »
Food Health TidingsUK Probes 36 Infant Illness Reports Linked to Recalled Infant Formula UK Probes 36 Infant Illness Reports Linked to Recalled Infant Formula Read Post »
Health TidingsFrom Launch to Halt: Hims & Hers’ Semaglutide Reversal From Launch to Halt: Hims & Hers’ Semaglutide Reversal Read Post »
Health TidingsPfizer Backs TrumpRx, Reduce Drug Prices in the U.S. Pfizer Backs TrumpRx, Reduce Drug Prices in the U.S. Read Post »
Health TidingsFibrobiologics Fetches Canadian Patent for Cachexia in Chronic Diseases Fibrobiologics Fetches Canadian Patent for Cachexia in Chronic Diseases Read Post »
Health TidingsTrumpRx.gov Goes Live, Drug Pricing and Policy in One Platform TrumpRx.gov Goes Live, Drug Pricing and Policy in One Platform Read Post »
Health TidingsEisai and Biogen Report Growing Real-World Use of Leqembi in Early Alzheime... Eisai and Biogen Report Growing Real-World Use of Leqembi in Early Alzheime... Read Post »
Health TidingsFDA Takes Aim at Non-Approved Compounded GLP-1 Drugs FDA Takes Aim at Non-Approved Compounded GLP-1 Drugs Read Post »
Health TidingsNovo Nordisk Accuses Hims & Hers of Illegal Semaglutide Compounding, Ci... Novo Nordisk Accuses Hims & Hers of Illegal Semaglutide Compounding, Ci... Read Post »
Health TidingsBMS and J&J Rethink Anticoagulation with Factor Xia BMS and J&J Rethink Anticoagulation with Factor Xia Read Post »
Health TidingsSimcere Doses First Patient in Anti-Stroke SIM0811 Trial Simcere Doses First Patient in Anti-Stroke SIM0811 Trial Read Post »
Health TidingsEli Lilly Q4 2025: Mounjaro and Zepbound Fuel 43% Growth Eli Lilly Q4 2025: Mounjaro and Zepbound Fuel 43% Growth Read Post »
Health TidingsValneva and Butantan Start IXCHIQ Chikungunya Vaccination Pilot in Brazil Valneva and Butantan Start IXCHIQ Chikungunya Vaccination Pilot in Brazil Read Post »
Health TidingsNovo Nordisk Reports 10% Sales Growth in 2025 as Wegovy Pill Launch Strengt... Novo Nordisk Reports 10% Sales Growth in 2025 as Wegovy Pill Launch Strengt... Read Post »
Health TidingsSPARC’s Sezaby Approval Unlocks Rare Pediatric Priority Review Voucher SPARC’s Sezaby Approval Unlocks Rare Pediatric Priority Review Voucher Read Post »
Health TidingsAstraZeneca Faces FDA Delay for At-Home Saphnelo SC in SLE AstraZeneca Faces FDA Delay for At-Home Saphnelo SC in SLE Read Post »
Health TidingsFDA Issues Complete Response Letter for Anaphylm Sublingual Epinephrine Fil... FDA Issues Complete Response Letter for Anaphylm Sublingual Epinephrine Fil... Read Post »
Health TidingsFDA Issues CRL for Pharming’s Joenja in Pediatric APDS Patients FDA Issues CRL for Pharming’s Joenja in Pediatric APDS Patients Read Post »
Health TidingsCARDAMYST™ Now Available in U.S. Pharmacies: A New Self-Administered Opti... CARDAMYST™ Now Available in U.S. Pharmacies: A New Self-Administered Opti... Read Post »
Health TidingsUltrahuman Partners With Click Therapeutics to Transform Migraine Managemen... Ultrahuman Partners With Click Therapeutics to Transform Migraine Managemen... Read Post »
Drugs Safety Alert Health TidingsFDA Issues Warning Letter to Telangana’s Palamur Biosciences Over GLP Ris... FDA Issues Warning Letter to Telangana’s Palamur Biosciences Over GLP Ris... Read Post »
Health TidingsJapan Honors Daiichi Sankyo with Prime Minister’s Award for EZHARMIA, the... Japan Honors Daiichi Sankyo with Prime Minister’s Award for EZHARMIA, the... Read Post »
Health TidingsAquestive Therapeutics Reports FDA-Identified Deficiencies in Anaphylm NDA,... Aquestive Therapeutics Reports FDA-Identified Deficiencies in Anaphylm NDA,... Read Post »
Health TidingsFDA Issues Complete Response Letter for Atara’s EBVALLO in EBV-Positive P... FDA Issues Complete Response Letter for Atara’s EBVALLO in EBV-Positive P... Read Post »
Health TidingsNestlé Baby Formula Recall 2026: What We Know About the Recall & Cereu... Nestlé Baby Formula Recall 2026: What We Know About the Recall & Cereu... Read Post »
Health TidingsVanda Therapeutics Receives Second FDA CRL for HETLIOZ in Jet Lag Disorder ... Vanda Therapeutics Receives Second FDA CRL for HETLIOZ in Jet Lag Disorder ... Read Post »
Health Tidings ResearchAbbott Launches Libre Assist in Libre App to Improve In-the-Moment Food Dec... Abbott Launches Libre Assist in Libre App to Improve In-the-Moment Food Dec... Read Post »
Health TidingsWegovy Pill Now Available in the U.S.: First Oral GLP-1 Weight-Loss Medicin... Wegovy Pill Now Available in the U.S.: First Oral GLP-1 Weight-Loss Medicin... Read Post »
